Motif

Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, 6 months after second doses, finds study of over 7 million adults

  • 21 July 2022
Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today [20 July],…

Cochrane review published on 1p19q detection in glioma

  • 8 March 2022
University of Bristol researchers have contributed to an NIHR funded update to the Cochrane review on 1p19q detection in glioma, which has just been published. Gliomas are a type of brain tumour (cancer). There are different types of glioma, with different changes in their genetic material. One of the…

Regular exercise reduces the risk of and death from pneumonia, study suggests

  • 7 December 2021
People who exercise regularly can reduce their risk of developing and dying from pneumonia, new research has found.  The study, led by researcher the University of Bristol, and funded by the National Institute for Health Research, Bristol Biomedical Research Centre (NIHR Bristol BRC) analysed, for the first time, ten population…

Professor Jonathan Sterne presents to US Food and Drug Administration on COVID-19 boosters

  • 17 September 2021
Professor Jonathan Sterne, Deputy Director of the National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC), has presented evidence to the US Food and Drug Administration (FDA) on COVID-19 vaccination boosters today, Friday 17 September. The presentation is part of the FDA’s advisory committee meeting to discuss…

New population-wide health data resource to accelerate research on COVID-19 and cardiovascular disease in England

  • 20 April 2021
For the first time, a new linked health data resource covering 54.4 million people – over 96 per cent of the English population – is now available for researchers from across the UK to collaborate in NHS Digital’s secure research environment. This resource will enable vital research to take place…

NIHR Bristol BRC to benefit from internship programme to tackle underrepresentation of Black people in science

  • 20 April 2021
The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC), a partnership between the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will host intern Angel Obierozie this summer as part of the Health Data Research UK (HDR UK) programme to…

Young people co-create COVID school study animation with researchers

  • 30 March 2021
As most pupils have now returned to school following lockdown, the COVID-19 school study, run by University of Bristol researchers, has also resumed fully. The study (also known as CoMMinS) aims to test thousands of pupils and staff for infection, in participating primary and secondary schools across Bristol. The…

Bristol researchers to collaborate on national study to understand long COVID

  • 25 February 2021
What is long COVID and how can diagnosis be improved? Using data from electronic health records at a national scale alongside information from thousands of participants in the UK’s population-based cohort studies, these and other questions will be tackled following an announcement on 18 February of a nationwide long COVID…

Genetic study of proteins is a breakthrough in drug development for complex diseases

  • 8 September 2020
An innovative genetic study of blood protein levels, led by researchers in the MRC Integrative Epidemiology Unit (MRC-IEU) at the University of Bristol, has demonstrated how genetic data can be used to support drug target prioritisation by identifying the causal effects of proteins on diseases. Working in collaboration with…